Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Common Equity (2017 - 2025)

Historic Common Equity for Catheter Precision (VTAK) over the last 9 years, with Q3 2025 value amounting to $6.8 million.

  • Catheter Precision's Common Equity fell 4712.3% to $6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.8 million, marking a year-over-year decrease of 4712.3%. This contributed to the annual value of $11.8 million for FY2024, which is 4452.41% down from last year.
  • According to the latest figures from Q3 2025, Catheter Precision's Common Equity is $6.8 million, which was down 4712.3% from $6.8 million recorded in Q2 2025.
  • Over the past 5 years, Catheter Precision's Common Equity peaked at $35.9 million during Q1 2023, and registered a low of $6.8 million during Q3 2025.
  • For the 5-year period, Catheter Precision's Common Equity averaged around $15.9 million, with its median value being $14.3 million (2024).
  • Its Common Equity has fluctuated over the past 5 years, first skyrocketed by 14298.85% in 2023, then crashed by 5726.62% in 2025.
  • Quarter analysis of 5 years shows Catheter Precision's Common Equity stood at $13.7 million in 2021, then tumbled by 32.28% to $9.3 million in 2022, then surged by 128.87% to $21.2 million in 2023, then plummeted by 44.52% to $11.8 million in 2024, then plummeted by 42.32% to $6.8 million in 2025.
  • Its Common Equity was $6.8 million in Q3 2025, compared to $6.8 million in Q2 2025 and $7.9 million in Q1 2025.